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Dr Jonathan Mann (1947 - 1998), health visionary 
and activist, highlighted the significance of human 
dignity in healthcare, particularly with respect to 
violations of human dignity. Recognising the social 
marginalisation, stigmatisation and lack of respect 
for the dignity and rights of people with HIV/AIDS, he defined the 
relationship between human dignity and human rights in healthcare. 
In a paper published after his death he brought to our attention that 
although ‘all human beings are born free and equal in dignity and 
rights’, dignity comes before the rights. To Mann,[1] human dignity 
is ‘the bedrock of all that follows … the wellspring and basis for 
universal human rights’.
Human dignity ‘is a linguistic currency that will buy you a 
basketful of extraordinary meanings’.[2] To encapsulate its meaning 
in a manner relevant to people with birth defects. I will use Nora 
Jacobson’s[3] definition contained in her comprehensive review of 
dignity and health:
Human dignity is the inherent and inalienable value that belongs 
to every human being simply by virtue of being human. Human 
dignity is held by the species, by collectives (groups or peoples), 
and by individuals. It cannot be measured or weighed or destroyed; 
nor is it contingent, conditional, contextual, or comparative.[3]
This is intuitively understandable, encompassing religious and 
secular approaches to human dignity. Jacobson[3] concludes that both 
allow ‘at the collective level … justification for sociopolitical ideals of 
equity and justice’.
Mann,[1] recognising the complexity in adequately defining human 
dignity, turns rather to classifying violations of human dignity in 
healthcare. He places these into four categories: being ignored or 
insufficiently acknowledged; being seen, but only as a member of a 
group; having one’s personal space transgressed involuntarily; and 
humiliation.
People with birth defects, that is with any structural or functional 
abnormality present from birth, certainly in Mann’s terms, suffer 
marginalisation, discrimination and stigmatisation.[1,4] From a health 
sciences and public health perspective, their presence, until recently, 
was ignored or insufficiently acknowledged.[1] It can be argued that 
when seen, they are seen as a group whose needs are all too often 
attended to as a lesser priority than those of the whole. Collectively, 
they were for millennia ‘distinguished and separated’ from the family 
of humankind, that is, humiliated.[1] In essence, I believe that their 
human dignity has been, until recently, impaired.[1]
In what follows I will describe a brief history of birth defects 
until the mid 1940s, and thereafter detail the international efforts to 
develop a cogent healthcare approach and policies for people with 
birth defects. In conclusion, I will describe the current situation, 
particularly in middle- and low-income nations, after the World 
Health Organization (WHO)’s May 2010 World Health Assembly 
(WHA) decision to make birth defects a global health priority.[5]
Looking back at birth defects
People with birth defects have been part of the human condition since 
humankind first walked the earth. Early humankind’s reaction to 
birth defects, that is those born with severe structural abnormalities, 
included ‘admiration, awe or terror’.[6] Responses included killing 
them, sometimes making images of their likeness in drawings, 
sculptures and carvings, and at times idolising or mythologising the 
images.
Our first knowledge of people with a birth defect is the statue of 
conjoined twins, the Goddess of Anatolia. Dating from 6500 BC, 
it was found in 1962 in southern Turkey.[6] Since then images of 
people with congenital malformations have been found worldwide, 
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Since first meeting and working with Trefor Jenkins in 1990, I have 
appreciated his devotion to and teaching of the ethical practice 
of medicine, and his insistence on according people, particularly 
patients, human dignity and thus their rights. In applying his 
principles he has quietly, and with dignity, shown courage beyond 
the measure of most men.
In this article I wish to honour that commitment by considering 
how the impairment of human dignity for people with birth 
defects arose over time, and then recognise the organisations and 
individuals who have worked assiduously, particularly over the last 
65 years, to achieve dignity for people with birth defects. 
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in different countries and cultures. Noah, following a description by 
his great-grandfather, the prophet Enoch, is possibly the first person 
described with a birth defect – albinism.[7]
The Tablets of Nineveh, containing the first written record 
of congenital malformations (loosely in this paper structural 
abnormalities), were discovered in the ruins of Babylon and date to 
the 7th century BC. One tablet describes 62 different malformations, 
each with a prognostic statement, mostly adverse, from the Babylonian 
diviners. Thus, ‘if a woman gives birth to an infant that wants [for] 
both ears, there will be mourning in the country and the country will 
be lessened [diminished]’.[6]
Divination from infants and children with malformations, which 
continued overtly into the Middle Ages and covertly to the 20th 
century in Europe, did not, however, give a cause for these problems. 
For aetiology, many theories have been proposed over time and in 
different cultures and countries. Among these is maternal impression, 
the concept that the development of the fetus is influenced by 
parental psychological factors around conception or in pregnancy. 
Thus things seen by the parents, particularly the pregnant woman, 
can by photographic transmutation affect the fetus. For example, a 
prevalent myth was that looking at monkeys, because of their head 
shape, was a cause of microcephaly or anencephaly. Not only visual 
images are considered to cause abnormality. Maternal shock, stress, 
worry and alarm could produce malformation,[6] and such ideas 
persist today.
More extreme is the ancient idea that malformed children were 
the product of the crossbreeding of humans and animals. Possibly 
having its origin in Egypt and India, there is evidence of this belief 
being upheld in Europe and America in the late 17th century. Related 
to it was the theory, particularly prevalent in 15th and 16th century 
Europe, that malformed children were caused by hybridisation of 
the mother and some demonic being.[6] In the absence of scientific 
knowledge, superstition will take its place, and even when science 
steps in to fill the void, displacing the superstition from the collective 
psyche is not automatic, as evidenced by the existence of some of these 
superstitions today. Against this background it is easily understood 
how past concepts about congenitally malformed children induced 
violations of human dignity for people with birth defects, and more 
recently have retarded the acquisition of this dignity.
Overturning such myths began in the 16th century with the 
growing knowledge of embryology. Among the first contributors, 
William Harvey (1578 - 1657) introduced the teratology concept of 
congenital malformations being the result of arrested embryological 
development.[6] Further work on this concept by Étienne Geoffroy 
Saint Hilaire (1772 - 1844) showed that arrested development could 
be caused by environmental agents, thus giving the first causative 
factor for birth defects.[6,8] However, it was his son and successor, 
Isidore Geoffroy Saint Hilaire (1805 -1861), who arguably, but 
unknowingly, struck the first blow for human dignity for people with 
birth defects. He recognised that congenital malformations were 
more common than naturalists at that time considered.[9] Jonathan 
Mann,[1] describing the process of clarification of new problems in 
healthcare, when referring to the epidemiology of the problem notes 
that ‘the issue of concern is often found to be more extensive than 
was assumed’. To my knowledge, Saint Hilaire’s observation on the 
frequency of congenital malformations is the first intimation of the 
extent of the problem of birth defects, a problem that was only to be 
fully understood more than 180 years later. However, he had begun 
the process of allowing people with birth defects to be acknowledged.
Perhaps more significantly, Isidore Saint Hilaire, in conjunction 
with Charles Darwin (1809 - 1882), is responsible for ensuring that 
people with birth defects are not distinguished and separated from 
the group or social norm, that is, collectively humiliated.[1] The group 
or social norm in this instance is the species, humankind. The early 
history of people with birth defects depicts them as a distinct group, 
not essentially human, whose existence was caused by hybridisation 
with animals or demonic figures or who were other-worldly beings, 
mythologised or idolised in images.[6]
Darwin, in On the Origin of Species[10] and based on Saint Hilaire’s 
work, considered congenital malformations in plants and animals as 
‘some considerable deviation in one part, either injurious or not useful 
to the species … but they graduate into varieties … and monstrosities 
(congenital malformations) cannot be separated by any clear line from 
mere variations’. He affirmed that naturalists include in one species its 
congenital malformations and varieties.[10] In The Descent of Man,[11] 
Darwin confirmed that ‘[M]onstrosities, which graduate into slight 
variations, are likewise so similar in man and the lower animals … the 
same terms can be used for both, as has been shown by Saint Hilaire’. 
The combined efforts of Saint Hilaire and Charles Darwin thus brought 
people with birth defects firmly into the human family.
However, Darwin’s work, totally independent of himself, led to 
horrendous consequences for people with birth defects in the late 
19th and 20th centuries. On a misreading of Darwin’s work and its 
inappropriate application to society (persons, groups and races), his 
cousin Francis Galton proposed the concept of eugenics. Galton first 
defined eugenics in 1883, but refined his definition and concepts over 
time. In a paper read in 1904 before a Sociological Society meeting 
in the London University’s School of Economies, he defined it as ‘the 
science that deals with all influences that improve the inborn qualities 
of a race; also those that develop them to the utmost advantage’.[12] Its 
aim was ‘to bring as many influences as can be reasonably employed 
to cause the useful classes in the community to contribute more than 
their proportion to the next generation’.[12] To achieve this, Galton was 
far more interested in, and motivated mainly for, what is now termed 
positive eugenics – his ‘augmentation of the favoured stock’. He 
considered that ‘The possibility of improving the race of a nation … 
is far more important than repressing the productivity of the worst.’[12]
While eugenics never officially gained favour in the UK and 
was opposed by such doyens of human genetics as J B S Haldane, 
Lancelot Hogben and Julian Huxley, its emigration to other countries, 
particularly the USA, Canada, Scandinavia and Germany, resulted in 
its transmogrification into appalling legislated and practised negative 
eugenics.[13]
Negative eugenics prescribes improving the quality of the human 
race by eliminating or excluding biologically inferior people from the 
population.[13] The definition of ‘biologically inferior’ was broadly, 
socially and politically based and biased, bearing little resemblance to 
biology, let alone reality. The inhumane consequences of this in the 
USA are starkly described in Stephan J Gould’s essay ‘Carrie Buck’s 
daughter’,[14] which vilifies the 1927 Supreme Court decision in Buck 
vs Bell. Chief Justice Oliver Wendell Holmes, in his infamous majority 
decision, had said:
It is better for all the world, that instead of waiting to execute 
degenerate offspring for crime, or let them starve for their 
imbecility, society can prevent those who are manifestly unfit from 
continuing their kind. The principle that sustains compulsory 
vaccination is broad enough to cover Fallopian tubes. Three 
generations of imbeciles is enough.[14]
Carrie Buck, along with over 50 000 others in state institutions, was 
sterilised. She was later considered to be of normal intelligence, albeit 
unsophisticated![14]
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There is little doubt that people with birth defects, ‘three generations 
of imbeciles’, were central to Holmes’ decision. But worse was to 
follow. In Nazi Germany between 1939 and 1945, following the 
Euthanasia Action (Aktion T4) ordered personally by Adolf Hitler on 
his private stationery, children with congenital disorders were put to 
death. They were murdered by State decree.[15]
New era, new approach
In 1948, in a brief moment of universal enlightenment and rationality, 
the world’s nations ratified the United Nation’s Universal Declaration 
of Human Rights (UDHR). What happened prior to this has 
resonance with the story above and to follow.
In June 1941, fourteen Allied nations signed the Inter-Allied 
Declaration, the founding step of the United Nations (UN). Two 
months later President Franklin Delano Roosevelt (FDR) and 
Winston Churchill signed the Atlantic Charter, a set of principles 
for international collaboration for maintaining world peace and 
security. On 1 January 1942, representatives from 26 Allied nations 
signed the Declaration by United Nations. After World War II the 
UN Charter was ratified in October 1945 and the first General 
Assembly was held in London on 10 January 1946. An early order 
of business was to complement the UN Charter with a road map to 
guarantee the rights of all peoples. The UN committee to draft the 
UDHR was chaired by Eleanor Roosevelt, widow of FDR. The first 
sentence of the UDHR recognises that ‘the inherent dignity and the 
equal and inalienable rights of all members of the human family is the 
foundation of freedom, justice and peace in the world’.[16,17] Thus began 
an era wherein, despite the inhumanity of Man towards his fellow 
Man that preceded it, people globally now have a framework to turn 
to, to achieve justice. This includes doctors and others responsible for 
the healthcare of people with birth defects.
FDR developed polio at 39 years of age in 1921. In 1938, at his 
behest, the National Foundation for Infantile Paralysis, later the 
March of Dimes, was founded, in his words ‘to lead, direct, and 
unify the fight on every phase of this sickness’. For FDR the new 
Foundation, in the words of historian Saul Benison, ‘… stood as an 
affirmation of the value of conserving human life and dignity’.[18] In 
1958, the March of Dimes made a remarkable decision. Founded to 
defeat polio, by the mid-1950s its task largely complete, the March 
of Dimes required a new mission. Turning away from an infectious 
disease to the field of non-communicable disorders, it chose to 
confront the challenge of birth defects. In this it was the first major 
organisation, national or international, to enter the field.[18]
The March of Dimes decision preceded the 1959 planning of the 
first international study on the epidemiology of birth defects, by the 
WHO, and the birth of the field of clinical genetics as announced 
by Dr Victor McKusick.[19,20] The latter is considered to have resulted 
from the burgeoning knowledge in the basic science fields of inborn 
errors of metabolism, cytogenetics, immunogenetics, population 
genetics and molecular genetics. The time was ripe for a clinical arm 
to translate that knowledge into healthcare for people with birth 
defects.
There is another, equally important reason why the time was right 
for the introduction of medical genetic services. In 1963 Dr Candau, 
Director-General of the WHO, in his opening address to the WHO 
Expert Committee on Human Genetics and Public Health, noted that 
‘with increasing control of infant mortality and infectious diseases, 
inherited abnormalities are assuming a proportionately greater 
importance in medical practice’. What Dr Candau refers to is health 
transition, otherwise known as epidemiological transition.[21,22]
Health transition occurs positively in most countries and is the 
change in population health (decreasing infant and child mortality 
rates with increasing longevity) and patterns of diseases in a country 
or region consequent on socioeconomic, educational, infrastructural 
and healthcare development and improvement. These initially bring 
about a reduction of infant and childhood deaths from infectious 
diseases and malnutrition, ensuring that more people can live longer 
into middle age, and then into old age as the process continues. With 
these changes, the pattern of diseases transforms from predominantly 
infectious diseases to non-communicable disorders, chronic disorders 
of later life, which often have a genetic component to their cause, and 
birth defects, which now attain public health significance.[21]
From 1959 to today we have witnessed remarkable developments 
in human and medical genetics, an amazing upsurge in knowledge 
and technology.[23] More remarkable, I believe, is how rapidly this 
new knowledge and technology has been translated into healthcare, 
particularly for people with birth defects. And this has been done 
with great attention to ensuring that the translation, and its practice in 
medicine, is ethically undertaken. Missteps have occurred, something 
to be expected in such a complex field, but these were for the most 
part recognised early and remedial action was taken.
Thus in a short 50 years, medical genetic services underpinned by 
ethical considerations, particularly the autonomy of those affected 
and their parents, have flourished. From the healthcare perspective 
these services acknowledge people with birth defects, who as a 
group now have their health needs integrated into healthcare and 
prioritised. By the turn of the 21st century these services were widely 
available to the populations in high-income (developed) nations. 
They highlighted industrialised nations’ successful health transition 
and the need therein for healthcare for people with or at risk of 
birth defects.[21,24,25] However, the healthcare benefits derived from 
the human and medical genetic revolution accrued little advantage 
to the millions of people born with birth defects (and their parents) 
in developing nations.[21,24,25] This was because ‘the common view [is] 
that a genetics service is an inappropriate luxury [in developing 
countries] where malnutrition and infection are still important 
problems’.[26] In the early 1980s a different view emerged. The main 
authors of this view were Dr Anver Kuliev, head of the Hereditary 
Diseases Programme at the WHO, and Professor Bernadette Modell, 
of University College London, who worked with him as a WHO 
expert advisor. The thrust to cross the last divide in achieving human 
dignity in healthcare for all people with birth defects began and was 
to take 30 years.
Kuliev and Modell recognised that health transition was proceeding 
in many developing nations, and for these countries developing 
medical genetic services was a looming priority. They understood 
that ‘inherited and other chronic diseases are more common [in 
developing countries], and their burden falls much more heavily 
on the family’, and that, because of circumstances and health 
services being very different in these countries, a new approach to 
offering medical genetic services was required. Their suggestion 
was ‘approaches that can be applied at the community level … a 
group of community genetic services, relevant to many aspects of 
primary health care’. The question was ‘when and how to introduce 
community genetics services into developing health systems’.[26] When 
developing countries should introduce medical genetic services was 
to take up some time and effort, but was ultimately extraneous to the 
process. The real issue was to how to introduce and develop these 
services. The answer was eventually offered in the March of Dimes 
Global Report on Birth Defects.[21] All countries require medical 
genetic services, but these have to be appropriate to their needs and 
current circumstances. For most developing nations the clinical 
services will mainly be community genetic services, or aspects 
thereof, integrated into and offered through primary healthcare.[21] 
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However, this realisation was some time in the future, and much had 
to be achieved before it was appreciated.
As medical genetic services were established in high-income 
countries, so they were started in developing nations. Individuals 
from developing countries trained in medical genetics in high-
income countries and on returning home established academic 
medical genetic departments, research-orientated but offering 
clinical services, much as in the high-income countries.[25] These 
academic clinical services tended to provide only limited access for 
the majority of the population.
There were two notable exceptions to these approaches in developing 
countries at that time. One medical geneticist from the developing 
world, who recognised this problem and wrote and spoke in an effort 
to change the approach, was the Argentinean Dr Victor Penchaszadeh. 
A medical geneticist and human rights activist, he was to play a central 
role in the future development of approaches to healthcare for people 
with birth defects and their parents in developing countries. The 
other was Cuba.[27] In the 1980s and early 1990s Cuba established the 
most comprehensive medical genetic service in the developing world, 
offering universal genetic healthcare to its population.
The insight and efforts of these early campaigners bore fruit in 
the 1990s. The work of different individuals and organisations began 
to converge to form a network dedicated to providing appropriate 
medical genetic services, mainly through primary healthcare, in 
developing nations.
Foremost among the organisations were the March of Dimes and 
the WHO. In 1992 Dr Michael Katz, following an outstanding career 
in paediatrics at Columbia University’s College of Physicians and 
Surgeons, was appointed Senior Vice President for Research and 
Global Programs at the March of Dimes. In 2006 he wrote a paper 
outlining the remarkable successes achieved by the March of Dimes 
in its fight against polio, and later through its support of research 
in human and medical genetics.[28] This included sponsoring James 
Watson’s fellowship to the UK that resulted in his collaborating 
with Francis Crick to publish their paper on the structure of 
DNA. In concluding, Dr Katz mentioned another March of Dimes 
accomplishment: the March of Dimes Global Report on Birth 
Defects.[21] I believe that the work of the March of Dimes Global 
Programs will in time be considered alongside that which has been 
achieved in the organisation’s genetic research portfolio.
In November 1997, Michael Katz and Ysbrand Poortman visited 
South Africa. Representing the World Alliance of Organizations for 
the Management and Prevention of Congenital Disorders (WAO), 
established in 1994 as an international consortium to increase 
awareness of birth defects through education and financial support, 
they held a meeting with three South African medical geneticists. 
At the conclusion of this meeting the WAO issued the Cape Town 
Declaration. Recognising the significant number of children born 
with birth defects in developing nations, and the need to translate 
current knowledge and technology to services appropriate for their 
healthcare, the Declaration recommended that an international 
conference should be held to discuss implementing these goals. What 
the Cape Town Declaration did not address was the need for the 
provision of medical genetic services in developing countries to be 
confronted by the WHO. Michael Katz offered to raise the issue with 
the WHO in Geneva.
In 1996, independent of the above activities, the Eastern 
Mediterranean Regional Office of the WHO, under the directorship 
of Dr Ala Alwan, held a meeting of regional medical genetic 
experts to discuss approaches for community control of genetic and 
congenital disorders. The international advisor to this meeting was 
Bernadette Modell, and the report produced was the first of its kind 
to focus on community approaches to healthcare for people with or 
at risk of having a child with a birth defect.[29] The report still has 
relevance today.
Independently of each other, Michael Katz and Ala Alwan, now 
based in Geneva, cleared the way for two landmark meetings to be 
held in 1999. Michael Katz raised the funding to enable the Human 
Genetics Programme of the WHO, in conjunction with the WAO, 
to convene a meeting of expert advisors in The Hague in January of 
that year. Chaired by Victor Penchaszadeh, this gathering highlighted 
two significant issues. The first was the lack of reliable empirical 
epidemiological data on birth defects from developing countries. 
The second was the primacy of providing services for the care of 
people with birth defects in developing countries. Care was defined 
as diagnosis, treatment and counselling, with psychosocial support 
for people with birth defects as well as their parents. Historically, in 
most industrialised nations, the focus had been on the provision of 
preventive services.[24]
The second meeting, arranged by Ala Alwan in Cairo in December 
1999, looked specifically at primary healthcare approaches for people 
with or at risk of birth defects. This group recommended a three-
phase approach for medical genetic services in developing countries: 
(i) to produce a structured country plan (Health Needs Assessment); 
(ii) to undertake intervention studies based on this plan; and (iii) to 
implement services based on the success of the intervention studies. 
Again, recognising the paucity of available epidemiological data, the 
meeting made practical recommendations for how countries could 
undertake base-line epidemiological studies.[30]
The turn of the century brought with it the very real prospect of 
medical genetic services finally being made available, in a meaningful 
way, in developing countries. Plans were laid to do pilot programmes 
in selected countries. From these it was hoped that sufficient 
knowledge, data, including epidemiological data, and experience 
would be acquired to change existing misperceptions regarding 
the need for these services in developing countries. In turn it was 
considered that the successful undertaking of these national pilot 
projects and their translation to national medical genetic services 
would drive the globalisation of these services, bringing with it 
human dignity, and in turn rights, for people with birth defects.
Jointly sponsored by the South African National Department of 
Health, the March of Dimes and the Centers for Disease Control 
(CDC), Atlanta, USA, the 1st International Conference on Birth 
Defects and Disabilities in the Developing World was successfully 
held in Johannesburg, South Africa, in September 2001. Emanating 
out of the WAO Cape Town Declaration, this was the first of five 
bi-annual conferences to be held in different regions of the world. 
The sixth is to be held in the Philippines in November 2013.
But storm clouds were gathering. In 2001 the WHO discovered a 
new holy grail – genomics and world health.[31] The WHO attempted 
to get medical geneticists and others involved with medical genetic 
services in developing countries to fully espouse its Genomic and 
World Health Programme. At a WHO meeting of expert advisors on 
‘Collaboration in Medical Genetics’, held in Toronto in April 2002, 
neither collaboration nor consensus was achieved.
In 2001, Ala Alwan was posted to Jordan as the WHO representative. 
Most of those who had previously been involved with the WHO in 
the field of medical genetic services in developing countries now 
worked to advance their cause outside of its sphere of influence. 
There was much to do. The 1999 meetings had highlighted the lack 
of adequate global epidemiological data on birth defects. Without 
such data it would be difficult to persuade governments in developing 
countries, let alone the WHO, of the need for medical genetic services 
in developing countries.
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In 1998, the WHO initiated a programme to document childhood 
mortality from congenital anomalies.[32] Congenital anomalies cover 
significantly fewer disorders than the term birth defects. They 
include structural abnormalities of genetic origin – chromosomal 
abnormalities, multifactorial malformations and some single-
gene defects. Excluded are all functional abnormalities, including 
the haemoglobin disorders, glucose-6-phosphate dehydrogenase 
deficiency and occulocutaneous albinism (common in Africa), 
some single-gene defects, and post-conception disorders due to 
abnormalities of the fetal environment (e.g. fetal alcohol syndrome 
and congenital rubella syndrome).
After the 1999 Cairo meeting, Bernadette Modell began work 
on modelling the global birth prevalence of birth defects. The basic 
principle for deriving this modelled database was the same as that 
concurrently being applied by the WHO to congenital anomalies. [21,34] 
However, the Modell Birth Defects Database encompassed all birth 
defects and sourced important data from two largely unknown but 
important studies.[33,34] She completed her work towards the end of 2002.
Meeting in Lyon in April 2001, representatives of patient-parent 
support groups from around the world, under the chairmanship 
of Ysbrand Poortman (a global doyen of patient-parent support 
for people with birth defects), considered options for creating an 
international organisation. Convening again in Lyon in 1993, the 
International Genetic Alliance of Parent and Patient Organisations 
(IGA) was established. The IGA collaborates with the organisations 
previously mentioned and works with its own agenda to promote 
medical genetic services, research, technologies and access to 
information,  to alleviate the burden of birth defects on individuals, 
families and communities.
Two significant events occurred in 2004. The 2nd International 
Conference on Birth Defects and Disabilities in the Developing World 
took place in the Great Hall in Beijing, China. In his address, before 
an audience of almost 1 000 people, the Chinese National Deputy 
Minister of Health highlighted the global need for healthcare services 
for people with birth defects. In addition, he opened a declaration, 
to be forwarded to the WHO, for consideration and signature by the 
delegates, and proposed 15 September as World Birth Defects Day.
Then the March of Dimes commissioned its Global Report 
on Birth Defects (the Report) in 2004. The Modell Birth Defects 
Database was reconfigured for easier access and analysis, and used 
as the basis for the report. Published in early 2006, the Report – 
including the Modell Birth Defects Database – received worldwide 
press attention and prompted an immediate response from the WHO. 
The Report’s figures for the total birth prevalence of genetic and 
partially genetic (multifactorial) birth defects far exceeded previous 
considerations.[21] More disquieting for the WHO was that the figures 
for childhood deaths from birth defects exceeded those previously 
published by a factor of six.[21,32,35] Given that the WHO child health 
policy is predicated on such data, and that the Report had adverse 
implications for the achievement of Millennium Development Goal 4 
(MDG 4), the WHO’s response was to be expected.
Four months later, at a joint WHO-March of Dimes expert advisors 
meeting in Geneva, the experts endorsed the March of Dimes Global 
Report on Birth Defects’ modelled estimates for the global birth 
prevalence of, and deaths from, birth defects.[4] Isidore Saint Hilaire’s 
observation on the frequency of birth defects was supported, and a 
major advance towards achieving human dignity in healthcare for 
people with birth defects had been made.
Professor Irma Nippert has been integrally involved in the 
development and delivery of medical genetic services in Europe 
since the 1980s. She joined the global movement at the meeting 
held in The Hague in 1999. A medical sociologist and an expert in 
medical genetic healthcare issues related to women and children, she 
brought a critical perspective to all proceedings. In 2003 she became 
the WAO chairperson and with her global network of colleagues and 
organisations tackled the practical issues that had been neglected 
after the world health and genomics issue.
Following EuroGentest, a European Union initiative to 
standardise and harmonise genetic testing in Europe, Irma Nippert 
initiated the CAPABILITY programme.[36] This was a European 
Commission-funded programme, started in 2005, to investigate 
how to translate current knowledge and technology into practice in 
developing countries and to see if standards could be harmonised 
with those being established for Europe by EuroGentest.[37] Three 
developing countries, Argentina, Egypt and South Africa, were 
involved. Valuable lessons were learnt on how to initiate and 
develop medical genetic services. In Argentina, the programme 
initiated in one province has now been extended to others. 
Following the Cairo 1999 concept, CAPABILITY developed an 
approach for Health Needs Assessment that developing countries 
could use. Then the PHG Foundation, based in Cambridge, UK, a 
CAPABILITY consortium partner, put together a toolkit to assist in 
the performance of a Health Needs Assessment.[38]
Following CAPABILITY, Irma Nippert initiated Genetic Testing 
in Emerging Economies (GenTEE) in 2010, a project designed to 
assess the current medical genetic service development and capacity 
of eight emerging economies. The GenTEE report is being finalised 
prior to publication. One concern noted during the project was that 
most of the countries have not used the WHO proposed community 
genetic model for the universalisation of their services. They have 
tended to follow the industrialised country academic centre model, 
thereby limiting access to these services by large portions of their 
populations, particularly the poor.
In 2008, Ala Alwan returned to the WHO in Geneva as Assistant 
Director-General for Noncommunicable Diseases and Mental Health. 
Under his guidance the executive board of the WHO, at the request 
of China, placed a document on birth defects before the WHA in 
May 2010. In consideration of that document, the WHA passed 
resolution WHA63.17[5] on 21 May. This resolution recognised, 
among other issues, the contribution of birth defects to infant and 
childhood mortality and that services for the care and prevention of 
birth defects, including community genetic services, were necessary 
to reduce this mortality, to help countries to attain MDG 4. It also 
recognised that the infrastructure was not in place in developing 
countries to acquire the necessary empirical epidemiological data to 
assess and recognise the public health significance of birth defects, 
and this in turn led to limited resources being allocated to services 
for the care and prevention of birth defects.
Mindful of the above, the WHA urged member states to raise 
awareness among all relevant stakeholders about the importance 
of birth defects as a cause of child morbidity and mortality; set 
priorities, commit resources, and develop plans and activities for 
integrating effective interventions for the care and prevention of birth 
defects into existing maternal, reproductive and child health services 
and social welfare; include ethical, legal and social issues associated 
with birth defects into their considerations; foster the development 
of parent-patient organisations; establish appropriate community 
genetic services; develop and strengthen registration and surveillance 
systems for birth defects within the framework of national health 
information systems; and take all necessary measures to ensure the 
full enjoyment by people with disabilities of all human rights and 
fundamental freedoms on an equal basis with other people. The 
vision of Bernadette Modell and Anver Kuliev and the endeavours of 
all involved had come to fruition.
Ethical, psychosocial and anthropological
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The future: attaining human rights
The passing of the WHO’s resolution WHA63.17[5] can be considered 
as the moment when people living with birth defects were finally 
offered human dignity in healthcare. In healthcare they are no longer 
ignored or insufficiently acknowledged; if seen as a group they are 
part of the community of humankind, no longer humiliated; and their 
needs are prioritised along with all others in our community. That 
realised, the next goal to achieve for people with birth defects is their 
human rights in healthcare. This can be accomplished by ensuring 
the best possible healthcare in the circumstances for all people with 
birth defects. Obviously best possible care is contingent upon each 
country’s situation and available resources. But once healthcare for 
people with birth defects is initiated, that is a beginning. As national 
circumstances improve, so can the healthcare for people with birth 
defects transform.
Some developing countries are on the road to achieving human 
rights in healthcare for people with birth defects. Their efforts, and 
the enthusiasm of the champions who undertake this task, mostly 
under trying circumstances, are laudable. They stand as examples 
for other developing countries to follow. Foremost among these 
countries is Iran. It is progressing towards comprehensive, universal 
medical genetic services for its over 44 million people, who live in a 
large country with diverse geographical and climatic conditions. It 
is achieving this by undertaking a Health Needs Assessment, based 
on both available empirical and modelled epidemiological data, and 
developing the clinical genetic services with a strong base in the 
community.[39]
Another concern raised by the GenTEE project is that in most of 
the emerging nations involved, a significant portion of healthcare for 
people with birth defects is rendered in the private healthcare sector. 
If this trend continues, and possibly increases, it could financially 
exclude millions of poor people with birth defects access to healthcare, 
raising issues concerning their human rights in healthcare.
In conclusion, Resolution WHA63.17[5] of the World Health 
Assembly of the World Health Organization gives people with birth 
defects human dignity in healthcare. It is to be hoped that their 
human rights will follow. The efforts of many organisations and 
people working towards this objective over the past 65 years ensure 
that Roosevelt’s ideal in establishing the National Foundation for 
Infantile Paralysis in 1938 has also been achieved for people with 
birth defects: ‘the affirmation of the value of conserving human life 
and dignity’.
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